Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results.
Kodali S, Hahn RT, George I, Davidson CJ, Narang A, Zahr F, Chadderdon S, Smith R, Grayburn PA, O'Neill WW, Wang DD, Herrmann H, Silvestry F, Elmariah S, Inglessis I, Passeri J, Lim DS, Salerno M, Makar M, Mack MJ, Leon MB, Makkar R; TRISCEND Investigators.
JACC Cardiovasc Interv. 2022 Mar 14;15(5):471-480. doi: 10.1016/j.jcin.2022.01.016.
PMID:35272771
Impact of tricuspid regurgitation on long-term survival.
Nath J, Foster E, Heidenreich PA.
J Am Coll Cardiol. 2004 Feb 4;43(3):405-9. doi: 10.1016/j.jacc.2003.09.036.
PMID:15013122
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study).
Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ.
Am J Cardiol. 1999 Mar 15;83(6):897-902. doi: 10.1016/s0002-9149(98)01064-9.
PMID:10190406
Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement.
Angellotti D, Mattig I, Samim D, Goebel B, Jantsch C, Rubinic B, Ruf T, Geisler T, Kessler M, Adam M, Stolz L, Dannenberg V, Kassar M, Stathogiannis K, Cesario V, Dumonteil N, Chrissoheris M, Spargias K, Baldus S, Rottbauer W, Gerçek M, Bartko PM, Lapp H, Dreger H, Hausleiter J, Lurz P, Windecker S, Rudolph V, Praz F.
JACC Cardiovasc Interv. 2025 Aug 11;18(15):1896-1909. doi: 10.1016/j.jcin.2025.06.002. Epub 2025 Jun 25.
PMID:40560107
Tricuspid regurgitation diagnosis and treatment.
Arsalan M, Walther T, Smith RL 2nd, Grayburn PA.
Eur Heart J. 2017 Mar 1;38(9):634-638. doi: 10.1093/eurheartj/ehv487.
PMID:26358570
Transcatheter Tricuspid Valve Replacement With the Novel System: 1-Year Outcomes From the TRAVEL Study.
Pan X, Lu F, Wang Y, Guo Y, Chen M, Meng X, Zhang H, Dong N, Shang X, Yang J, Liu Y, Wang J, Liu X, Guo H, Liu J, Qiao F, Ascione G, Cheung A, Modine T, von Bardeleben RS, Granada JF, Xu Z, Hu S.